A Narrow Ratio of Nucleic Acid to SARS-CoV-2 N-protein Enables Phase Separation

Overview

Journal bioRxiv

Date 2024 Apr 22

PMID 38645044

Authors

Patrick M Laughlin

Kimberly Young

Giovanni Gonzalez-Gutierrez

Joseph C Y Wang

Adam Zlotnick

Affiliations

Soon will be listed here.

Abstract

SARS-CoV-2 Nucleocapsid protein () is a viral structural protein that packages the 30kb genomic RNA inside virions and forms condensates within infected cells through liquid-liquid phase separation (). N, in both soluble and condensed forms, has accessory roles in the viral life cycle including genome replication and immunosuppression. The ability to perform these tasks depends on phase separation and its reversibility. The conditions that stabilize and destabilize N condensates and the role of N-N interactions are poorly understood. We have investigated LLPS formation and dissolution in a minimalist system comprised of N protein and an ssDNA oligomer just long enough to support assembly. The short oligo allows us to focus on the role of N-N interaction. We have developed a sensitive FRET assay to interrogate LLPS assembly reactions from the perspective of the oligonucleotide. We find that N alone can form oligomers but that oligonucleotide enables their assembly into a three-dimensional phase. At a ~1:1 ratio of N to oligonucleotide LLPS formation is maximal. We find that a modest excess of N or of nucleic acid causes the LLPS to break down catastrophically. Under the conditions examined here assembly has a critical concentration of about 1 μM. The responsiveness of N condensates to their environment may have biological consequences. A better understanding of how nucleic acid modulates N-N association will shed light on condensate activity and could inform antiviral strategies targeting LLPS.

References

Lopez-Munoz A, Kosik I, Holly J, Yewdell J . Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity. Sci Adv. 2022; 8(31):eabp9770. PMC: 9348789. DOI: 10.1126/sciadv.abp9770. View

Lu S, Ye Q, Singh D, Cao Y, Diedrich J, Yates 3rd J . The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein. Nat Commun. 2021; 12(1):502. PMC: 7820290. DOI: 10.1038/s41467-020-20768-y. View

Wu W, Cheng Y, Zhou H, Sun C, Zhang S . The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics. Virol J. 2023; 20(1):6. PMC: 9831023. DOI: 10.1186/s12985-023-01968-6. View

Wu C, Chen P, Yeh S . Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables coronavirus transition from discontinuous to continuous transcription. Cell Host Microbe. 2014; 16(4):462-72. PMC: 7104987. DOI: 10.1016/j.chom.2014.09.009. View

Wang Y, Zhao D, Liu X, Chen X, Xiao W, Feng L . Early administration of Paxlovid reduces the viral elimination time in patients infected with SARS-CoV-2 Omicron variants. J Med Virol. 2022; 95(1):e28443. PMC: 9880690. DOI: 10.1002/jmv.28443. View

Zhao H, Wu D, Nguyen A, Li Y, Adao R, Valkov E . Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids. iScience. 2021; 24(6):102523. PMC: 8103780. DOI: 10.1016/j.isci.2021.102523. View

Chen C, Chang C, Chang Y, Sue S, Bai H, Riang L . Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA. J Mol Biol. 2007; 368(4):1075-86. PMC: 7094638. DOI: 10.1016/j.jmb.2007.02.069. View

Chau B, Chen V, Cochrane A, Parent L, Mouland A . Liquid-liquid phase separation of nucleocapsid proteins during SARS-CoV-2 and HIV-1 replication. Cell Rep. 2023; 42(1):111968. PMC: 9790868. DOI: 10.1016/j.celrep.2022.111968. View

Kleer M, Mulloy R, Robinson C, Evseev D, Bui-Marinos M, Castle E . Human coronaviruses disassemble processing bodies. PLoS Pathog. 2022; 18(8):e1010724. PMC: 9439236. DOI: 10.1371/journal.ppat.1010724. View

10.

Zlotnick A . Are weak protein-protein interactions the general rule in capsid assembly?. Virology. 2003; 315(2):269-74. DOI: 10.1016/s0042-6822(03)00586-5. View

11.

Morse M, Sefcikova J, Rouzina I, Beuning P, Williams M . Structural domains of SARS-CoV-2 nucleocapsid protein coordinate to compact long nucleic acid substrates. Nucleic Acids Res. 2022; 51(1):290-303. PMC: 9841419. DOI: 10.1093/nar/gkac1179. View

12.

Telenti A, Arvin A, Corey L, Corti D, Diamond M, Garcia-Sastre A . After the pandemic: perspectives on the future trajectory of COVID-19. Nature. 2021; 596(7873):495-504. DOI: 10.1038/s41586-021-03792-w. View

13.

Lo Y, Lin S, Wang S, Wang C, Chiu Y, Huang T . Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein. FEBS Lett. 2012; 587(2):120-7. PMC: 7089611. DOI: 10.1016/j.febslet.2012.11.016. View

14.

Iserman C, Roden C, Boerneke M, Sealfon R, McLaughlin G, Jungreis I . Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid. Mol Cell. 2020; 80(6):1078-1091.e6. PMC: 7691212. DOI: 10.1016/j.molcel.2020.11.041. View

15.

Wu C, Qavi A, Hachim A, Kavian N, Cole A, Moyle A . Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain. iScience. 2021; 24(6):102681. PMC: 8168301. DOI: 10.1016/j.isci.2021.102681. View

16.

Katen S, Zlotnick A . The thermodynamics of virus capsid assembly. Methods Enzymol. 2009; 455:395-417. PMC: 2798165. DOI: 10.1016/S0076-6879(08)04214-6. View

17.

Cong Y, Kriegenburg F, de Haan C, Reggiori F . Coronavirus nucleocapsid proteins assemble constitutively in high molecular oligomers. Sci Rep. 2017; 7(1):5740. PMC: 5515880. DOI: 10.1038/s41598-017-06062-w. View

18.

Klein S, Cortese M, Winter S, Wachsmuth-Melm M, Neufeldt C, Cerikan B . SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. Nat Commun. 2020; 11(1):5885. PMC: 7676268. DOI: 10.1038/s41467-020-19619-7. View

19.

Hagan M, Mohajerani F . Self-assembly coupled to liquid-liquid phase separation. PLoS Comput Biol. 2023; 19(5):e1010652. PMC: 10212142. DOI: 10.1371/journal.pcbi.1010652. View

20.

Wang S, Dai T, Qin Z, Pan T, Chu F, Lou L . Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity. Nat Cell Biol. 2021; 23(7):718-732. DOI: 10.1038/s41556-021-00710-0. View